Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective: To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials.gov: NCT02282397). Setting: 25 endocrinology practices in North America. Patients: 158 adults who had had type 2 diabetes for a median of 17 years (interquartile range, 11 to 23 years). Participants were aged 35 to 79 years (mean, 60 years [SD, 10]), were receiving multiple daily injections of insulin, and had hemoglobin A1c (HbA1c) levels of 7.5% to 9.9% (mean, 8.5%). Intervention: Random assignment to CGM (n = 79) or usual care (control group, n = 79). Measurements: The primary outcome was HbA1c reduction at 24 weeks. Results: Mean HbA1c levels decreased to 7.7% in the CGM group and 8.0% in the control group at 24 weeks (adjusted difference in mean change, -0.3% [95% CI, -0.5% to 0.0%]; P = 0.022). The groups did not differ meaningfully in CGM-measured hypoglycemia or quality-of-life outcomes. The CGM group averaged 6.7 days (SD, 0.9) of CGM use per week. Limitation: 6-month follow-up. Conclusion: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control. Because few insulin-treated patients with type 2 diabetes currently use CGM, these results support an additional management method that may benefit these patients. Primary Funding Source: Dexcom.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Benefits of CGM in this population include reductions in A1C, fewer severe hypoglycemia events in children and adults, increased TIR, as well as significant reductions in hospitalizations for severe hypoglycemia and DKA.156,162–168”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“The clinical efficacy of CGM has been demonstrated in numerous retrospective studies and RCTs of individuals with T1D regardless of insulin delivery method.156–161”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“In addition, CGM use has been reported to reduce fear of hypoglycemia and increase confidence in avoiding/treating hypoglycemia.156,174,175”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
In the citing paper
“Numerous studies have demonstrated significant clinical benefits of CGM use in people with diabetes regardless of insulin delivery method (1-15).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Self-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 3×
“org), was identical to that of a parallel trial in patients with type 1 diabetes (12), which also had a second phase assessing insulin pump initiation.”
BackgroundResultSelf-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Self-citationClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Cited by
Items 401–500 of 636
Wang, Q., Zhou, Y., Wang, W., Ou, Y., Wu, X., Chen, J., Li, X., & Li, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1464071 · Cited by 9
The Use of Continuous Glucose Monitoring in Older People With Type 2 Diabetes
Rao, H., Fakourfar, N., Sun, C., & Lewis, J. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.556 · Cited by 5
Closing in on closed-loop systems for type 2 diabetes
Beck, R. W. (2023) · Nature Medicine · doi:10.1038/s41591-022-02127-0 · Cited by 8
Self-citationPfützner, A., Tencer, B., Stamm, B., Mehta, M., Sharma, P., Gilyazev, R., Jensch, H., Thomé, N., & Huth, M. (2023) · Sensors · doi:10.3390/s23094541 · Cited by 5
Advancements in Diabetes Technology Are Outpacing the Evidence
Rickson, M., Wright, E. E., Bindal, A., & Ghonim, L. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0145 · Cited by 7
Jadav, R. K., Yee, K. C., Turner, M. R., & Mortazavi, R. (2024) · Healthcare · doi:10.3390/healthcare12151542 · Cited by 5
Thomas, A., Haak, T., Tombek, A., Kulzer, B., Ehrmann, D., Kordonouri, O., Kröger, J., Schubert-Olesen, O., Kolassa, R., Siegmund, T., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241267768 · Cited by 5
Parsiani, R., Grace, T., Green, C. R., Castle, J. R., & Wilson, L. M. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_773_24 · Cited by 5
Migdal, A. L., Abrahamson, M. J., Peters, A. L., & Vint, N. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1493216 · Cited by 5
The pharmacist’s role in continuous glucose monitoring
Isaacs, D. M. (2020) · Pharmacy Today · doi:10.1016/j.ptdy.2020.04.014 · Cited by 5
Gibson, R., Oliver, N. S., McGowan, B. M., Vetter, C., Palla, L., D'Annibale, M., Linley, J., Lorencatto, F., & Guess, N. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14714 · Cited by 6
External validation of a classifier of daily continuous glucose monitoring (CGM) profiles
Lobo, B. J., & Kovatchev, B. P. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105293 · Cited by 5
Frank, S., Hames, K. C., Jbaily, A., Park, J. H., Stroyeck, C., & Price, D. A. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0189 · Cited by 6
Self-citationSpecial Issue “The Prevention, Treatment, and Complications of Diabetes Mellitus”
Arroba, A. I., & Aguilar‐Diosdado, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185305 · Cited by 5
Diabetestechnologie (Update 2023)
Schütz-Fuhrmann, I., Rami-Merhar, B. M., Fröhlich-Reiterer, E. E., Hofer, S. E., Tauschmann, M., Mader, J. K., Resl, M., Kautzky‐Willer, A., Winhofer-Stöckl, Y., Laimer, M., et al. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02165-9 · Cited by 5
Current Obstacles (With Solutions) in Type 2 Diabetes Management, Alongside Future Directions
Belančić, A., Majanović, S. K., & Rahelić, D. (2023) · Diabetology · doi:10.3390/diabetology4030031 · Cited by 5
Comment on Grino et al: Suitability of Flash Glucose Monitoring for Detection of Hypoglycemia
Seibold, A., & Brines, R. D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819838534 · Cited by 5
Tiano, S. M., Moczygemba, L. R., Hinds, A., Jokerst, J. R., Litten, K. P., Roscoe, C. A., & Sharma, R. (2025) · JAPhA Practice Innovations · doi:10.1016/j.japhpi.2025.100045 · Cited by 5
Wiggins, K. T., Hall, T. L., Jortberg, B. T., Dickinson, W. P., Dickinson, L. M., Parascando, J. A., Fernald, D. H., Sobczak, C., Oser, S. M., & Oser, T. K. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02903-0 · Cited by 7
Son, H., Moon, S. J., & Cho, Y. M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01830-8 · Cited by 7
Inequity in Continuous Glucose Monitor (CGM) Prescribing Behaviors in Primary Care
Milosavljevic, J., Schechter, C. B., Fazzari, M. J., Mathias, P., Mathew, J. T., & Agarwal, S. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09923-7 · Cited by 5
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
Aleppo, G., Carlson, A. L., McGill, J. B., Alshannaq, H. A., Galindo, R. J., Kruger, D. F., Levy, C. J., Matuoka, J. Y., Ilham, S., Umpierrez, G. E., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251414980 · Cited by 6
Self-citationHofner, M., Hurnaus, P., DiStefano, D., Philip, S., Kim, S., Shaw, J. L. V., & Waring, A. C. (2024) · JMIR Diabetes · doi:10.2196/53835 · Cited by 5
Lind, N., Christensen, M. B., Hansen, D. L., Willaing, I., & Nørgaard, K. (2024) · Diabetic Medicine · doi:10.1111/dme.15321 · Cited by 6
Lever, C. S., Williman, J. A., Boucsein, A., Watson, A. S., Sampson, R. S., Sergel‐Stringer, O. T., Keesing, C., Wheeler, B. J., de Bock, M. I., & Paul, R. G. (2025) · Diabetic Medicine · doi:10.1111/dme.70025 · Cited by 5
Barua, S., Upadhyay, D., Berube, L. T., Popp, C. J., Curran, M., Pompeii, M. L., Hu, L., Alemán, J. O., Bergman, M., & Sevick, M. A. (2025) · Diabetic Medicine · doi:10.1111/dme.70052 · Cited by 5
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group
Irace, C., Avogaro, A., Bertuzzi, F., Buzzetti, R., Candido, R., Prato, S. D., Bartolo, P. D., Fiorina, P., Giorda, C. B., & Giorgino, F. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70059 · Cited by 7
Nemlekar, P. M., Hannah, K. L., Green, C. R., & Norman, G. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70089 · Cited by 4
Diamond, K. (2023) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000831 · Cited by 6
Morris-Murray, M., & Frazzitta, M. A. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.10-b.s30 · Cited by 11
Flint, K. L., O’Connor, M. Y., Sabean, A., Ashley, A. L., Zheng, H., Yan, J., Steiner, B. A., Anandakugan, N., CALVERLEY, M. M., Bartholomew, R. A., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0628 · Cited by 4
Neue Therapieoptionen mit kontinuierlich gemessenen Glukosedaten – Empfehlungen für die Praxis
Seufert, J., Deiss, D., Gölz, S., Haak, T., Klausmann, G., Kroeger, J., Lobmann, R., Pfeiffer, A. F. H., Schnell, O., Seibold, A., et al. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0978-4537 · Cited by 4
Blissett, D. B., Attvall, S., & Hellmund, R. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01099-7 · Cited by 4
Courtney, A., Smith, D., & Forde, H. E. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03322-9 · Cited by 4
Hurteau, L. B., & Hogue, N. J. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.5.550 · Cited by 7
Thomas, A., Haak, T., Tombek, A., Kulzer, B., Ehrmann, D., Kordonouri, O., Kroeger, J., Schubert-Olesen, O., Kolassa, R., Siegmund, T., et al. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1849-2137 · Cited by 4
Designing the Glucose Telemetry for Hospital Management: From Bedside to the Nursing Station
Satyarengga, M., Siddiqui, T., & Spanakis, E. K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1067-4 · Cited by 5
Guideline Development for Medical Device Technology: Issues for Consideration
Battelino, T., Brosius, F. C., Ceriello, A., Cosentino, F., Green, J., Kellerer, M., Koob, S., Kosiborod, M., Lalic, N. M., Marx, N., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221093355 · Cited by 5
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies
Kruger, D. F., Parkin, C. G., Hirsch, I. B., Aleppo, G., McGill, J. B., Galindo, R. J., Levy, C. J., Umpierrez, G. E., Grunberger, G., & Bergenstal, R. M. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251332956 · Cited by 4
Self-citationSatisfaction with Continuous Glucose Monitoring in Pregnant Patients with Type 1 and Type 2 Diabetes
Shrestha, K. S., & Battarbee, A. N. (2024) · American Journal of Perinatology · doi:10.1055/a-2442-7090 · Cited by 4
Wilmot, E. G., Ajjan, R., Cheah, Y. S., Choudhary, P., CRANSTON, I. C., Elliott, R. A., Evans, M. L., Iqbal, A., Kamaruddin, S., Barnard-Kelly, K. D., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090154 · Cited by 6
Behnke, A., Lucas, K. S., Parkin, C. G., Reddy, V., Orlowski, M., & Edwards, A. (2025) · Diabetes Spectrum · doi:10.2337/ds24-0085 · Cited by 3
Willis, M. S., Nilsson, A., Alshannaq, H. A., Matuoka, J. Y., & Norman, G. J. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2025-0125 · Cited by 4
Accuracy of continuous glucose monitoring in critically ill patients
Santamaria, J. D., Selers, E., & Reid, D. (2025) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2025.100118 · Cited by 5
Lazzaroni, E., Cimino, V., Gandolfi, A., Tinari, C., Bucciarelli, L. G., Morpurgo, P. S., Nasr, M. B., Fiorina, R. M., Pastore, I., Baruffaldi, L., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf165 · Cited by 4
Sharma, A. K., Lee, A., Mehta, S., Panjwani, Q., & Burugapalli, B. S. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261423934 · Cited by 3
Schipper, S. B. J., Karagiannis, T., Zaccardi, F., Remmelzwaal, S., Blom, M. T., Dagan, N., Schoonmade, L. J., Langendam, M. W., Mb, J., Jensen, W., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06789-0 · Cited by 4
Kieu, A., Govender, R. D., Östlundh, L., & King, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050027 · Cited by 3
Medina, A. M. G., Parra, D., Carrillo, D. C. H., Gómez, C. M., Múñoz, Ó., Caicedo-Correa, S. M., Kerguelen, A., Hortúa, L. M. R., Pantoja, Ó. D. L., Valencia, M. A. U., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241232659 · Cited by 6
Diabetes self‐care activities and its correlates in patients with diabetic neuropathy
Kang, Y., & Park, I.-K. (2024) · Journal of Clinical Nursing · doi:10.1111/jocn.17380 · Cited by 3
Disease Detection Using Ensemble Model in Machine Learning
Mohapatra, R., Giri, P. K., Sayyad, I., Sahu, A., Brahma, B., & Kamila, N. K. (2025) · SN Computer Science · doi:10.1007/s42979-025-03753-4 · Cited by 3
Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region
Alshaikh, A., BAKHSH, A. M. K., Alsagheir, A., El-Laboudi, A. H., Al-Mohanadi, D. H., Alawadi, F., Elbadawi, H., Alzubaidi, L. M. Y., Al‐Sofiani, M. E., Farooqi, M. H., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251393740 · Cited by 4
Pedone, E., Laurenzi, A., Allora, A., Bolla, A. M., & Caretto, A. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00021 · Cited by 3
Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
Lu, J., Zeng, Y., Yi, X., Zhang, H., Zhu, L., Jiang, L., Li, J., Zhou, W., Zhu, H., & Aijun, X. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03110-3 · Cited by 3
Short‐term removal of exercise impairs glycemic control in older adults: A randomized trial
Reynolds, L. J., Williams, T. M., Harden, J. E., Twiddy, H., & Kearney, M. L. (2023) · Physiological Reports · doi:10.14814/phy2.15591 · Cited by 3
Fernández, A. C., Almeida, J. M. G., Vegas-Aguilar, I. M., Porca, C., Quintana, T. C., Pérez, C. T., Tinahones, F. J., & Bellido, D. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04577 · Cited by 4
Bhattacharyya, S., Muchhala, S., & Jhaveri, K. S. (2023) · Journal of Advances in Medical and Pharmaceutical Sciences · doi:10.9734/jamps/2023/v25i6621 · Cited by 3
Pros and cons of continous glucose monitoring
Ciechański, M., Witkowska, E., Ostańska, A., Szafran, A., Wiśniewska, K., Piasek, L., Godek, G., Więcław, K., Stańko, K., & Terelak, W. (2023) · Journal of Medical Science · doi:10.20883/medical.e873 · Cited by 4
Artificial intelligence in diabetes management
Thomas, A., Gopi, V. P., & Francis, B. (2024) · Advances in Artificial Intelligence · doi:10.1016/b978-0-443-19073-5.00002-1 · Cited by 3
La variabilité glycémique : un facteur de risque singulier à conjuguer au pluriel
Monnier, L., Colette, C., Bonnet, F., & Owens, D. R. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.11.003 · Cited by 3
Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused
Nguyen, Q., Iyyavoo, A. A., & Parkin, C. G. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070837 · Cited by 4
Advancing Diabetes Quality Measurement in the Era of Continuous Glucose Monitoring
Khan, M., Wahid, N., Musser, T., Bergenstal, R. M., Ebekozien, O. A., Snow, K. J., Thomas, K., & Aprigliano, C. M. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231163518 · Cited by 3
Self-citationArguello, V., & Freeby, M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-2121 · Cited by 4
Инсулинотерапия сахарного диабета второго типа
Gendeleka, G. F., & Gendeleka, A. N. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.1.2020.199130 · Cited by 4
Bailey, R. J., Calhoun, P. M., Chao, C., & Walker, T. C. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0384 · Cited by 3
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.23 · Cited by 3
Ranting in 2019: Are Things Improving?
Hirsch, I. B. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0004 · Cited by 3
Morrow, E. L., Spieker, A. J., Greevy, R. A., Roddy, M. K., & Mayberry, L. S. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09101-1 · Cited by 2
Kim, K. J., Park, Y. S., Sun, E., Jo, E., Shinn, J., Yim, H. W., Kim, C. O., & Kim, H. (2025) · Yonsei Medical Journal · doi:10.3349/ymj.2024.0261 · Cited by 3
Mnatzaganian, C. L., Bounthavong, M., Abalos, W., Chau, T., Nwosu, O., Yi, A., Saunders, I. M., & Kelly, P. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.102397 · Cited by 3
Glucose management indicator: Do we need device-specific equations?
Jávorfi, T., Kocsis, G., Svébis, M. M., Ferencz, V., Domján, B. A., Kézdi, Á., Hankó, H., Putz, Z., & Tabák, Á. G. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101661 · Cited by 4
Flint, K. L., Ting, T., Rivera, K., Tamang, P., Colling, C., Li, J. H., & Putman, M. S. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.001 · Cited by 3
Schiavon, M., Vella, A. V., & Man, C. D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2024 · Cited by 3
Eldin, A. G., & Nogid, A. (2025) · Journal of Pharmacy Technology · doi:10.1177/87551225251379742 · Cited by 2
JENDLE, J. H., Ilham, S., Alshannaq, H. A., Matuoka, J. Y., Pollock, R. F., Ahmed, W., & Norman, G. J. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01811-x · Cited by 2
Sebastian, S. A., Padda, I., Bimal, T., Varma, S., Collins, J. S. P., Ahmad, Z., & Safarova, M. S. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102043 · Cited by 3
Dennis, C., Allaire, J. C., Bouhairie, V. E., & Hirsch, I. B. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251403569 · Cited by 3
DECARA, C., Marney, A. M., GHOLAM, S., Skelly, J. M., & Gilbert, M. P. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag004 · Cited by 3
Chang, S., LU, Y., Ling, H., Zhang, G., Zhang, Y., Li, X., & Ln, Z. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261416870 · Cited by 2
Chan, C. P., Jagadesh, G. S., Bellary, S., & Baharani, J. (2026) · BMC Nephrology · doi:10.1186/s12882-026-04816-1 · Cited by 2
Bruttomesso, D., Petrie, J. R., Evans, M. L., Fleming, G. A., Hanaire, H. P., Holl, R. W., Sherr, J. L., Bergenstal, R. M., Heinemann, L., & Peters, A. L. (2026) · Diabetologia · doi:10.1007/s00125-025-06651-9 · Cited by 3
Self-citationKerrigan, J. A., Probst, D., & Sode, K. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118619 · Cited by 2
Giaccari, A., Gliozzo, G., Ciccarelli, G., Giuseppe, G. D., Castellano, C., Cum, S., Monache, L. D., Gallo, M., Lastretti, M., Medea, G., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02693-6 · Cited by 2
Ampudia‐Blasco, F. J., Ugarte, E., Chico, A. I., García-Alemán, J., & Galan-Barroso, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087270 · Cited by 3
Health-Care Disparities in the Use of Diabetes Technologies in the UK
Barnard-Kelly, K. D., & Parkin, C. G. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_1_23 · Cited by 3
Ye, Y., Acevedo-Mendez, B. A., Izard, S. M., & Myers, A. K. (2023) · Diabetes Spectrum · doi:10.2337/ds23-0013 · Cited by 2
Trolle, C., Christensen, M., & Hansen, K. W. (2024) · Diabetic Medicine · doi:10.1111/dme.15298 · Cited by 4
Massone, P., Barbieri, M., Angelucci, A., & Aliverti, A. (2024) · IEEE International Workshop on Sport, Technology and Research (STAR) · doi:10.1109/star62027.2024.10635992 · Cited by 2
Best practices and rationale for expanding Medicaid access to continuous glucose monitoring
King, C. A., & Lilly, A. N. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.10-b.s40 · Cited by 2
Oshman, L. D., Bhomia, N., Diez, H. L., Gabison, J. G., Gorin, S. S., Hafez, D., Hisamatsu, R., Heung, M., Jamison, C. D., KHOSROVANEH, K. L., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11520-z · Cited by 2
Maiorino, M. I., Martino, N. D., Angelino, S., Maio, A., Caruso, P., Petrizzo, M., Scappaticcio, L., Longo, M., Forestiere, D., Porcellini, C., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04405-6 · Cited by 4
Managing Diabetes in the Digital Age
Dugan, J. A., Ahmed, S., Vincent, M., Perry, R., & Young, C. F. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.003 · Cited by 2
Евгеньевна, Р. Г. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-286-292 · Cited by 3
Insulin Therapy in Type 2 Diabetes Mellitus
(2022) · The Singapore Family Physician · doi:10.33591/sfp.48.1.u2 · Cited by 2
Šoupal, J., Kao, K., Brandner, L., Grunberger, G., & Prázný, M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01422-4 · Cited by 2
Newer Outpatient Diabetes Therapies and Technologies
Kamal, N., Lee, K., & Aleppo, G. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.002 · Cited by 2
Slugocki, M., Bialonczyk, D., & Özdener-Poyraz, A. E. (2018) · Journal of Pharmacy Technology · doi:10.1177/8755122518813889 · Cited by 2
Glucose Management Using Continuous Glucose Monitors
Kang, Y. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.1.42 · Cited by 2
Grino, M., Alitta, Q., & Oliver, C. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818805749 · Cited by 2
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Zhang, F., & Zhong, Y. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2507995 · Cited by 2
Metadata
- Authors
- Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., Aronson, R., Toschi, E., Kollman, C., Bergenstal, R., & for the DIAMOND Study Group*
- Affiliations
- Joslin Diabetes Center (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-09-19
- Volume
- 167
- Issue
- 6
- Pages
- 365-374
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2753830550
- Semantic Scholar
- 4f35ac21c54271e1101cc587d928e543765ee06a
- Cited by
- 635
- References
- 31
- Citations by year
- 2026: 58 · 2025: 91 · 2024: 95 · 2023: 77 · 2022: 77 · 2021: 85 · 2020: 43 · 2019: 56 · 2018: 46 · 2017: 6
- FWCI
- 32.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, multiple daily insulin injections, glycemic control, HbA1c reduction, hypoglycemia, quality of life, usual care, type 1 diabetes
- MeSH terms
- Adult, Aged, Bacterial Proteins, Diabetes Mellitus, Type 2, Drug Administration Schedule, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Membrane Proteins, Middle Aged, Quality of Life, Blood Glucose Self-Monitoring, Patient Satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.